Presentation is loading. Please wait.

Presentation is loading. Please wait.

Research Informed Consent

Similar presentations

Presentation on theme: "Research Informed Consent"— Presentation transcript:

1 Research Informed Consent
Kristin Bialobok, MSN, RN, CCRC, CCRA Director Office of Research Education and Regulatory Management

2 Purpose of Consent ? Prospective Subject Will ..
Understand nature of research Be informed of purpose, risks, and benefits, and alternative therapies Make a Voluntary Decision about Participation

3 What rules do I follow? Federal Regulations Institutional Policy
21CFR Part 50 45CFR Part 46 Sponsor Request ICH Good Clinical Practice Guidelines E6 4.8

4 Is Informed Consent Always Essential?
EXCEPTIONS: IRB has granted a waiver of consent Life-threatening condition and Inability to communicate with the subject and Time is insufficient to obtain consent from subject’s legal representative and There is no alternative method of approved therapy Must Be Followed By notification of the IRB within 5 days review and evaluation of test article use by another physician obtain consent ASAP.

5 Research Consent Process
Consent Document Consent Discussion


7 Research Consent Document
21 CFR Basic Elements of IC

8 Research Consent Document
21 CFR Additional Elements

9 Research Consent Document
Readability Language that is easily understood Language must be appropriate to the population being studied Language translators should be qualified and IRB authorized Consider comprehension as well as readability Limit medical terminology Avoid informal speech

10 Research Consent Document
IRB Informed Consent (final version) Sponsor PI


12 Who has the Authority to Obtain Research Consent?
What do the regulations say? Silent What does ICH GCPs say? 4.1.5 – “the investigator should maintain a list of appropriately qualified persons to whom the investigator has delegated significant trial-related duties.” What does the institution say? Consideration: Nurse Practice Act

13 Informed Consent Process
Discussion between the physician and the participant. Review of information by research nurse/coordinator. All questions and concerns addressed. No exculpatory language Minimal chance of coercion/undue influence Allow adequate time Signatures obtained.

14 Informed Consent and Screening Procedures
Informed consent must be obtained prior to any protocol specific testing being conducted. If protocol specific testing done the same day as informed consent document signed, must be clear documentation of the chronological order in the medical record.


16 Completing the Document
All blank spaces completed No additions or deletions Signatures obtained FDA 21CFR 50- The patient or authorized representative shall sign and date the informed consent. OHRP 45 CFR 46- ….signed by the patient or legally authorized representative. ICH GCP E6 4.8 – …the informed consent should be signed and personally dated by the subject or legally authorized representative. Institutional Policies

17 Completing the Document
Document distribution FDA 21CFR 50- A copy of Informed Consent shall be given to the patient or representative. OHRP 45 CFR 46- A copy shall be given to the person signing the form. ICH GCP E6 4.8 – The subject should receive a copy of the signed and dated written informed consent form… Institutional Policies

18 Completing the Document
When do you need a witness? When presenting the informed consent document orally Use of a short form If required by the IRB Who can be the witness? ICH GCP – Impartial witness – a person who is independent of the trial, who cannot be unfairly influenced by people involved in the trial, who attends the informed consent process…


Protocol number or name of study Alternative treatment options discussed. A statement that the protocol, and the informed consent were reviewed with the participant, including the risks and benefits of the study. Time for questions to be asked and answered. Description of the participant’s decision Copy of consent was given to the participant DOCUMENTING THE PROCESS

21 RE-CONSENTING Participants must be informed of new information that may affect their willingness to take part in the research.


23 the parent/s or legal guardian
CONSENTING MINORS Minor Per state law – Texas=Under 18 years old informed consent process (on the child’s behalf) the parent/s or legal guardian Participant under 18 y

24 CONSENTING MINORS Depending on the type of research, the IRB
may make provisions for “assent” of children. Assent “A child’s affirmative agreement to be a participant in research. Mere failure to object should not, absent affirmative agreement, be construed as assent.” Need to specifically ask for the institution’s policy before auditing.

25 MDACC Flow Chart – Consenting Minors
Age >/=18 No Yes Subject and Person obtaining consent sign the ICD Parent/Guardian, witness, and Person obtaining consent sign the ICD Child Age 7-12 – Verbal Assent Only Child Age – Written Assent Required

26 Non-English Speaking Participants

27 Non-English Speaking Participants
Ideal is to use consent translated to participant’s native language 45 CFR (b) - “Short form written consent document…”

28 What do we look for as auditors?
Does ICD contain all required elements? Was ICD used for participant the most current IRB approved document at time of enrollment? Is a the ICD present in the participant’s medical record? Is a copy of the ICD present in the investigator’s file? Are all blank spaces completed?

29 What do we look for as auditors?
Does writing appear that participant signed and dated ICD? Is witness’s signature and date present, if needed? Is person’s who obtained consent signature and date present? Was delegation of authority to obtain consent appropriate? Do all date on the consent match? If dates do not match is explanation present in the on-study progress note?

30 What do we look for as auditors?
Is full informed consent process documented in progress note? Is participant a minor? If minor, is assent portion of the ICD completed? Is participant Non-English speaking? If Non-English speaking was institutional policy followed?

31 FDA Inspections and Informed Consent Statistics
% of the clinical investigators/sites inspected were cited for informed consent related issues. % of the investigators/sites who received OAI (Official Action Indicated) letters included informed consent citations. Good Clinical Practice A Question & Answer Reference Guide May 2008

32 Practice Time

Download ppt "Research Informed Consent"

Similar presentations

Ads by Google